<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02294071</url>
  </required_header>
  <id_info>
    <org_study_id>LHRI IRF</org_study_id>
    <nct_id>NCT02294071</nct_id>
  </id_info>
  <brief_title>Prospective Comparative Study of the Efficacy of Common Antipyretic Treatments in Febrile Children</brief_title>
  <official_title>Prospective Comparative Study of the Efficacy of Common Antipyretic Treatments in Febrile Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <brief_summary>
    <textblock>
      This study will examine in detail the immediate effects of three common treatments given to
      children with fevers to lower their temperature. Each child will be given either ibuprofen,
      acetaminophen, or a combination, and their temperature monitored at five-minute intervals.
      The temperature-lowering effects of each treatment will be compared to evaluate which is most
      effective.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is no substantial evidence that a fever lower than 41Â°C is harmful to the welfare of an
      otherwise healthy child, although they can be dangerous to children already in critical
      condition [1,2]. However, fevers in healthy children commonly cause anxiety in parents and
      caregivers, so parents and physicians often give antipyretic medications to lower the fever
      [3,4]. Ibuprofen and acetaminophen are two of the most commonly used medications in children.
      Most major pediatric medical associations agree about appropriate dosages for children, but
      give no clear guidelines on whether ibuprofen or acetaminophen should be used [3,5].
      Physicians commonly make the decision between the two based on their personal opinions of the
      efficacy and safety of the medications, or based on habit [6]. Survey data shows that more
      than half of physicians use combinations of both acetaminophen and ibuprofen to treat fever,
      either simultaneously or on an alternating schedule, with a variety of dosing patterns [6]. A
      majority of physicians believed there were established guidelines supporting this use, but in
      fact there are not [6].

      Combining the two medications is widely theorized to improve effectiveness, but clinical
      trials comparing combination treatments to ibuprofen and/or acetaminophen alone have shown
      inconsistent results [4,7-12]. Several pharmacodynamic studies have shown that ibuprofen and
      acetaminophen both produce their largest effects on temperature within the first hour
      following dosage [9,10,13-16]. Despite this, only one study has been performed examining the
      change in temperature at intervals shorter than 30 minutes, and that study used substandard
      monitoring methods [10].

      This study will use gold-standard monitoring methods to take temperatures every five minutes
      through the first one to four hours of treatment. Understanding the pattern of temperature
      change in the acute stages after dosing will help settle the debate about the optimal
      medication choice for treating childrens' fevers.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>temperature reduction from baseline</measure>
    <time_frame>4 hours</time_frame>
    <description>change in temperature from baseline at time of drug administration and at five minute intervals afterward for a minimum of one hour, maximum 4 hours</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Fever</condition>
  <arm_group>
    <arm_group_label>acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>acetaminophen 15mg/kg (max 975mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ibuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ibuprofen 10mg/kg (max 600mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>combination</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>acetaminophen 15mg/kg (max 975mg) and ibuprofen 10mg/kg (max 600mg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>oral liquid ibuprofen 10mg/kg (maximum 600 mg)</description>
    <arm_group_label>ibuprofen</arm_group_label>
    <arm_group_label>combination</arm_group_label>
    <other_name>Advil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>oral liquid acetaminophen 15mg/kg (max 975mg)</description>
    <arm_group_label>acetaminophen</arm_group_label>
    <arm_group_label>combination</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  fever between 38 and 41 Celsius (inclusive) on presentation to ER

          -  assessment by treating physician that patient requires antipyretic treatment

        Exclusion Criteria:

          -  known allergy or hypersensitivity to either study medication

          -  received any antipyretic medication in past eight hours

          -  patient requires admission to hospital

          -  co-morbidities indicating increased risk of complication

          -  assessment by treating physician that patient is medically unsuitable for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael J Rieder, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Western Ontario, Canada</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael J Rieder, MD</last_name>
    <phone>(519) 685-8500</phone>
    <phone_ext>58293</phone_ext>
    <email>mrieder@uwo.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lauren Faught, PhD</last_name>
    <phone>519-661-3221</phone>
    <email>lhanly2@uwo.ca</email>
  </overall_contact_backup>
  <reference>
    <citation>Mullins ME, Empey M, Jaramillo D, Sosa S, Human T, Diringer MN. A prospective randomized study to evaluate the antipyretic effect of the combination of acetaminophen and ibuprofen in neurological ICU patients. Neurocrit Care. 2011 Dec;15(3):375-8. doi: 10.1007/s12028-011-9533-8.</citation>
    <PMID>21503807</PMID>
  </reference>
  <reference>
    <citation>Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, Tada K, Tanaka K, Ietsugu K, Uehara K, Dote K, Tajimi K, Morita K, Matsuo K, Hoshino K, Hosokawa K, Lee KH, Lee KM, Takatori M, Nishimura M, Sanui M, Ito M, Egi M, Honda N, Okayama N, Shime N, Tsuruta R, Nogami S, Yoon SH, Fujitani S, Koh SO, Takeda S, Saito S, Hong SJ, Yamamoto T, Yokoyama T, Yamaguchi T, Nishiyama T, Igarashi T, Kakihana Y, Koh Y; Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care. 2012 Feb 28;16(1):R33. doi: 10.1186/cc11211. Erratum in: Crit Care. 2012;16(1):450.</citation>
    <PMID>22373120</PMID>
  </reference>
  <reference>
    <citation>Section on Clinical Pharmacology and Therapeutics; Committee on Drugs, Sullivan JE, Farrar HC. Fever and antipyretic use in children. Pediatrics. 2011 Mar;127(3):580-7. doi: 10.1542/peds.2010-3852. Epub 2011 Feb 28. Review.</citation>
    <PMID>21357332</PMID>
  </reference>
  <reference>
    <citation>Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, Johnson DW. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Cochrane Database Syst Rev. 2013 Oct 30;(10):CD009572. doi: 10.1002/14651858.CD009572.pub2. Review.</citation>
    <PMID>24174375</PMID>
  </reference>
  <reference>
    <citation>D Leduc SWCPSCPC. Temperature measurement in pediatrics. Canadian Pediatric Society. 2013.</citation>
  </reference>
  <reference>
    <citation>Mayoral CE, Marino RV, Rosenfeld W, Greensher J. Alternating antipyretics: is this an alternative? Pediatrics. 2000 May;105(5):1009-12.</citation>
    <PMID>10790455</PMID>
  </reference>
  <reference>
    <citation>Vyas FI, Rana DA, Patel PM, Patel VJ, Bhavsar RH. Randomized comparative trial of efficacy of paracetamol, ibuprofen and paracetamol-ibuprofen combination for treatment of febrile children. Perspect Clin Res. 2014 Jan;5(1):25-31. doi: 10.4103/2229-3485.124567.</citation>
    <PMID>24551584</PMID>
  </reference>
  <reference>
    <citation>Allan GM, Ivers N, Shevchuk Y. Treatment of pediatric fever: Are acetaminophen and ibuprofen equivalent? Can Fam Physician. 2010 Aug;56(8):773.</citation>
    <PMID>20705883</PMID>
  </reference>
  <reference>
    <citation>Erlewyn-Lajeunesse MD, Coppens K, Hunt LP, Chinnick PJ, Davies P, Higginson IM, Benger JR. Randomised controlled trial of combined paracetamol and ibuprofen for fever. Arch Dis Child. 2006 May;91(5):414-6. Epub 2006 Feb 7.</citation>
    <PMID>16464962</PMID>
  </reference>
  <reference>
    <citation>Hay AD, Costelloe C, Redmond NM, Montgomery AA, Fletcher M, Hollinghurst S, Peters TJ. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ. 2008 Sep 2;337:a1302. doi: 10.1136/bmj.a1302. Erratum in: BMJ. 2009;339:b3295.</citation>
    <PMID>18765450</PMID>
  </reference>
  <reference>
    <citation>Kramer LC, Richards PA, Thompson AM, Harper DP, Fairchok MP. Alternating antipyretics: antipyretic efficacy of acetaminophen versus acetaminophen alternated with ibuprofen in children. Clin Pediatr (Phila). 2008 Nov;47(9):907-11. doi: 10.1177/0009922808319967. Epub 2008 Jun 6.</citation>
    <PMID>18539869</PMID>
  </reference>
  <reference>
    <citation>Paul IM, Sturgis SA, Yang C, Engle L, Watts H, Berlin CM Jr. Efficacy of standard doses of Ibuprofen alone, alternating, and combined with acetaminophen for the treatment of febrile children. Clin Ther. 2010 Dec;32(14):2433-40. doi: 10.1016/j.clinthera.2011.01.006.</citation>
    <PMID>21353111</PMID>
  </reference>
  <reference>
    <citation>Brown RD, Kearns GL, Wilson JT. Integrated pharmacokinetic-pharmacodynamic model for acetaminophen, ibuprofen, and placebo antipyresis in children. J Pharmacokinet Biopharm. 1998 Oct;26(5):559-79.</citation>
    <PMID>10205771</PMID>
  </reference>
  <reference>
    <citation>Kauffman RE, Sawyer LA, Scheinbaum ML. Antipyretic efficacy of ibuprofen vs acetaminophen. Am J Dis Child. 1992 May;146(5):622-5.</citation>
    <PMID>1621668</PMID>
  </reference>
  <reference>
    <citation>Temple AR, Temple BR, Kuffner EK. Dosing and antipyretic efficacy of oral acetaminophen in children. Clin Ther. 2013 Sep;35(9):1361-75.e1-45. doi: 10.1016/j.clinthera.2013.06.022. Epub 2013 Aug 23. Review.</citation>
    <PMID>23972576</PMID>
  </reference>
  <reference>
    <citation>TrocÃ³niz IF, Armenteros S, Planelles MV, BenÃ­tez J, Calvo R, DomÃ­nguez R. Pharmacokinetic-Pharmacodynamic Modelling of the antipyretic effect of two oral formulations of ibuprofen. Clin Pharmacokinet. 2000 Jun;38(6):505-18.</citation>
    <PMID>10885587</PMID>
  </reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2014</study_first_submitted>
  <study_first_submitted_qc>November 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2014</study_first_posted>
  <last_update_submitted>November 17, 2014</last_update_submitted>
  <last_update_submitted_qc>November 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lawson Health Research Institute</investigator_affiliation>
    <investigator_full_name>Michael Rieder</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>acetaminophen</keyword>
  <keyword>ibuprofen</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Antipyretics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

